We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$417M
AUM Growth
-$24.5M
Cap. Flow
-$15.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$7.46M
2
LIN icon
Linde
LIN
+$6.13M
3
LOGI icon
Logitech
LOGI
+$3.75M
4
KO icon
Coca-Cola
KO
+$1.49M
5
AMZN icon
Amazon
AMZN
+$990K

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$14.3M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$7.54M
3
ALC icon
Alcon
ALC
+$5.41M
4
RACE icon
Ferrari
RACE
+$5.16M
5
CNH
CNH Industrial
CNH
+$2.87M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 15.28%
3 Consumer Discretionary 11.12%
4 Healthcare 10.96%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
726
Lumen
LUMN
$6.36B
$5.9K ﹤0.01%
476
PXD
727
DELISTED
Pioneer Natural Resource Co.
PXD
$5.83K ﹤0.01%
35
STRL icon
728
Sterling Infrastructure
STRL
$19.3B
$5.78K ﹤0.01%
255
-8,245
-97% -$184K
EXPD icon
729
Expeditors International
EXPD
$22.4B
$5.72K ﹤0.01%
48
-3,265
-99% -$409K
MPT
730
Medical Properties Trust
MPT
$2.91B
$5.46K ﹤0.01%
272
+216
+386% +$4.43K
CF icon
731
CF Industries
CF
$18.6B
$5.42K ﹤0.01%
97
-8,259
-99% -$396K
WAB icon
732
Wabtec
WAB
$50.1B
$5.34K ﹤0.01%
62
O icon
733
Realty Income
O
$61.3B
$5.25K ﹤0.01%
84
+75
+833% +$5.06K
MTX icon
734
Minerals Technologies
MTX
$2.25B
$5.24K ﹤0.01%
75
-2,396
-97% -$183K
ELS icon
735
Equity Lifestyle Properties
ELS
$12.7B
$5.08K ﹤0.01%
65
+61
+1,525% +$5K
NVRI icon
736
Enviri
NVRI
$626M
$5.05K ﹤0.01%
298
-9,533
-97% -$176K
DBRG icon
737
DigitalBridge
DBRG
$2.94B
$5.05K ﹤0.01%
209
-23
-10% -$634
EXTR icon
738
Extreme Networks
EXTR
$3.91B
$5.02K ﹤0.01%
510
-16,529
-97% -$174K
FTDR icon
739
Frontdoor
FTDR
$5.08B
$4.99K ﹤0.01%
119
-3,809
-97% -$174K
CXW icon
740
CoreCivic
CXW
$3.09B
$4.96K ﹤0.01%
557
-17,980
-97% -$175K
CRBP icon
741
Corbus Pharmaceuticals
CRBP
$171M
$4.86K ﹤0.01%
159
PRIM icon
742
Primoris Services
PRIM
$4.55B
$4.8K ﹤0.01%
196
-6,316
-97% -$170K
BAH icon
743
Booz Allen Hamilton
BAH
$8.77B
$4.76K ﹤0.01%
60
-948
-94% -$79.2K
CHKP icon
744
Check Point Software Technologies
CHKP
$13.7B
$4.75K ﹤0.01%
42
BSET icon
745
Bassett Furniture
BSET
$170M
$4.65K ﹤0.01%
257
ATI icon
746
ATI
ATI
$25.8B
$4.59K ﹤0.01%
276
-8,757
-97% -$166K
SSRM icon
747
SSR Mining
SSRM
$5.46B
$4.57K ﹤0.01%
314
DEA
748
Easterly Government Properties
DEA
$1.17B
$4.54K ﹤0.01%
88
HRC
749
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4.5K ﹤0.01%
30
IJH icon
750
iShares Core S&P Mid-Cap ETF
IJH
$123B
$4.47K ﹤0.01%
85

Similar funds

Exane Derivatives's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.

  • Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
  • Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
  • Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
  • Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
  • Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
  • Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
  • Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.